In an interview with Christine Moutier, MD, psychiatrist and chief medical officer of the American Foundation for Suicide Prevention, she speaks about how the current COVID-19 pandemic presents opportunities to improve suicide prevention efforts on multiple levels.
All articles by Tori Rodriguez, MA, LPC, AHC
An estimated 30% of patients who are prescribed antidepressant medications do not have an adequate response. In order to address these high rates of nonresponse to standard depression therapies, researchers continue to explore a wide range of other promising agents, including anti-inflammatory therapies and psilocybin.
The dual pandemics of COVID-19 and racism as public health crises have led to an awakening among non-Black Americans as to how rampant racism is in the field of psychiatry and other mental health disciplines.
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
Only 65.2% of adults surveyed in United States in 2014 reported that they consistently get at least 7 hours of sleep each night.
Various studies have consistently shown associations between recessions and worsening mental health, as indicated by increased rates of depression.
It is critical for clinicians to be aware of the unique risks and potential drug interactions that may affect MDD patients.
When the spread of COVID-19 began to necessitate physical distancing, telemedicine was suddenly recast in many settings as the only option rather than just a feasible alternative to in-person care.
Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.
Major depressive disorder (MDD) is commonly observed in medical settings, with a prevalence of up to 14% compared with 2% to 4% in the general population.1 Various studies have found rates of 12% to 18% in patients with diabetes, 15% to 23% in those with coronary heart disease, 23% to 54% in patients with multiple…
The number of deaths by suicide in spring 2019 highlighted the ripple effects of violence and sparked reports that a phenomenon called “suicide contagion” may have been a contributing factor in these incidents.
Researchers found that there a many factors that contribute to nonadherence to antipsychotic medication in patients with schizophrenia, including the patient’s perception that the physician is in alliance with their family, rather than listening to what he or she wants. Physicians who were interviewed by Psychiatry Advisor recommend listening to what is important to the patient. Weight gain associated with medications might be unacceptable to some patients, or medication-induced somnolence, which to some could be intolerable, might help severe insomnia in others.
The epidemic of opioid use disorder has led to substantial increases in new cases of HCV and HIV infection, as well as hospitalizations for other OUD-related infections.
A range of studies show that connections among social identification, perception, and interpretation of social situations affect quality of life in patients with major depressive disorders.
An estimated 25% of children and adolescents report having pain that persists for more than 3 months, with severe and disabling pain affecting 8% of this population.
The integration of technology into medicine has expanded into various uses in patients with Parkinson disease.
A growing body of research suggests there may be associations between common viral infectious such as Epstein Barr and Toxoplasma gondii and schizophrenia.
By increased connectivity within the insular cortex through listening to music, symptoms, including auditory hallucinations, are rehabilitated in patients with schizophrenia.
Along with its effects on the endocrine system, melatonin is involved in regulating certain parameters of the cardiovascular system and central nervous system.
Researchers found that there has been little attention paid to intervention to enhance treatment adherence in nonpsychotic major depression, so they outlined steps for engagement, retention, and adherence for these patients.
Whether negative symptoms are specified by category or across dimensions, discovering biomarkers to indicate specific treatment strategies is needed.
Transcranial direct current stimulation could be a viable alternative to medication and psychotherapy to treat pregnant women with depression, according to the results of a Canadian pilot study.
Despite the clear need for improved management of T2D in patients with SMI, there is scant evidence regarding effective treatment strategies for this group.
Noninvasive brain stimulation (NIBS) techniques are a potential alternative to the use of medications for the treatment of poststroke depression.
Latest News Your top articles for ThursdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses